MaxCyte, Inc. (LON:MXCT – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 1.19 and traded as high as GBX 1.26. MaxCyte shares last traded at GBX 1.24, with a volume of 745,949 shares traded.
MaxCyte Trading Up 9.4%
The company has a quick ratio of 14.38, a current ratio of 12.39 and a debt-to-equity ratio of 9.70. The company has a 50-day moving average price of GBX 1.19 and a 200-day moving average price of GBX 0.98. The company has a market capitalization of £1.48 million, a price-to-earnings ratio of -0.03 and a beta of 1.13.
MaxCyte Company Profile
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.
Recommended Stories
- Five stocks we like better than MaxCyte
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
